The Sub-Sero Study
Conditions: Schizophrenia; Psychosis Intervention: Drug: Pimavanserin 34 MG [Nuplazid] Sponsors: Bjorn H. Ebdrup; Rigshospitalet, Denmark; GCP unit, Copenhagen University Hospital; ACADIA Pharmaceuticals Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials